Metabolomics analysis of Bacillus amyloliquefaciens BNC5 pellet extracts comparing three conditions: BNC5 alone, BNC5 co-cultured with Ralstonia solanacearum whole cells (BNC5RSw), and RSw alone (dead cell background control)

This report presents the results of an untargeted metabolomics analysis comparing three clinical groups: Healthy controls (n=20), PreDiabetic patients (n=20), and Type 2 Diabetes (T2D) patients (n=20). Fifty metabolites were profiled across 60 samples.

Complete metabolomics pipeline comparing Healthy controls and T2D patients using R